How genomic testing and molecular markers are improving the landscape of advanced prostate cancer
December 13th 2021"I think that we have seen a lot of updates and advances in advanced prostate cancer generally, one of the biggest of these being PSMA-targeted lutetium," says Alicia K. Morgans, MD, MPH.